Ahammune Biosciences raised $5M in a Series A funding round led by pi Ventures to conduct Phase II human clinical trials for its vitiligo drug candidate.
Amount Raised
$5 Million
Round Type
Series A
PuneBiotechnologyHealth CareTherapeuticsInvestors
Description
Ahammune Biosciences has secured $5 million in a Series A funding round, with pi Ventures leading the investment. The funds will be used to advance clinical trials for their vitiligo drug and expand their patent portfolio.
Quick answer
Ahammune Biosciences raised $5 Million in a Series A round, dated September 24, 2024. Investors: Ian, Legacy Assets Llp, Kotak Alternate Assets, Ideaspring Capital, Unicornus Maximus Llp, Bipin Agarwal, Colossa Ventures and Capital2 B. Ahammune Biosciences is based in Pune, Maharashtra, India.
- How much did Ahammune Biosciences raise?
- Ahammune Biosciences raised $5 Million in a Series A round on September 24, 2024.
- Who invested in Ahammune Biosciences?
- Ian, Legacy Assets Llp, Kotak Alternate Assets, Ideaspring Capital, Unicornus Maximus Llp, Bipin Agarwal, Colossa Ventures and Capital2 B are named as investors in this round.
- What does Ahammune Biosciences do?
- Ahammune Biosciences is a biotechnology startup focused on drug discovery in the dermatological sector.
- Where is Ahammune Biosciences based and how big is it?
- Ahammune Biosciences is based in Pune, Maharashtra, India.
- Who are the decision-makers at Ahammune Biosciences?
- Fundz holds 2 contacts at Ahammune Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Ahammune Biosciences, and when
A new round usually means Ahammune Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ahammune Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ahammune Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ahammune Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ahammune Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAhammune Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.